Skip to content

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04888104
Enrollment
225
Registered
2021-05-17
Start date
2021-07-09
Completion date
2034-12-31
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Spinal Deformity, Kyphosis, Scoliosis

Keywords

Scoliosis, Kyphosis, Sagittal Imbalance

Brief summary

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Detailed description

Specific Aims: * Evaluate the safety and performance of posterior spinal fusion constructs supplemented with posterior spinolaminar fixation using the VersaTie System compared to posterior fixation constructs without VersaTie System supplementation in adult patients undergoing long posterior spinal fusion by evaluating intraoperative and postoperative complications, clinical and radiographic outcomes, patient-reported outcomes (PROs) and need for revision surgery. * Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery. * Develop and validate a standardized, universal complications classification system for spine surgery * Evaluate perioperative blood management approaches, transfusion requirements, including variance in thresholds for blood transfusion and associated complications for adult spinal deformity surgery * Assess impact of opioid use and pain management on patient cost, complications and outcomes * Evaluate optimal opioid and analgesic usage and protocols for standard work development * Evaluate clinical outcomes utilizing legacy patient reported outcome measures (PROMs) including modified Oswestry Disability Index (mODI), Scoliosis Research Society Questionnaire 22r (SRS-22r), Veterans RAND-12 (VR-12), and numeric pain rating scale (NRS) and compare the results of these legacy PROMs to outcomes scores as measured by the NIH Patient Reported Outcomes Measurement Information System (PROMIS) - PROMIS Anxiety, Depression, Pain Interference, Physical Function, and Social Satisfaction. Secondary aims for PROM research for this study include 1. Validation of the PROMIS tool for ASD 2. Establish a core set of PROMs for best practice guidelines for ASD 3. Evaluate patient reported outcome variance for ASD according to SRS-Schwab spine deformity type including variance in baseline PROM domains impacted and variance in improvement in PROM domains 4. Evaluate ASD outcomes compared to population norms and investigate/develop appropriate measures of clinically significant improvement * Evaluate clinical outcomes stratifying by patient chronological and physiological age * Evaluate measures to quantify patient physiological age including patient frailty for ASD and validate a frailty measurement system for ASD * Evaluate the role of functional tests in patient's baseline frailty assessment including hand manometer and Edmonton Frail Scale. See appendix, pages 17 & 18 for details. * Evaluate the contribution of patient frailty to patient outcomes, complications, cost of care, disability, and complications * Evaluate if patient frailty is a static measure or if frailty is a dynamic measure that can be improved through "pre-habilitation" and if the according associations with reductions in frailty correlate with reductions of cost, complications, and improvement in outcomes * Evaluate cost variance for ASD surgery according to patient, institution, and geographical region and evaluate the cost effectiveness of surgical intervention for ASD * Evaluate incidence of and risk factors for mental health (MH) compromise among ASD patients and establish best practice guidelines for assessing MH for ASD patients * Evaluate the association of MH with surgical complications, outcomes, hospital length of stay and cost for ASD surgery * Evaluate the association of social health surgical complications, outcomes, hospital length of stay and cost for ASD surgery and risk factors for routine (home) discharge vs. skilled nursing facility (SNF)/rehabilitation facility * Broaden the evaluation of the surgically treated ASD patient to maximize evaluation of the entirety of the episode of care to include steps that can be taken prior to surgery including "prehabilitation," pain management, and MH care to improve treatment outcomes, reduce cost, reduce hospital length of stay, reduce non-routing discharge and reduce early and late complications * Establish a core set of standard work guidelines to clinically and radiographically evaluate and treat ASD patients and evaluate the utility of standard work to improve outcomes for ASD and formulate best practice guidelines for surgical treatment of ASD * Develop predictive analytic algorithms to risk stratify for best/worst outcomes, complications, sentinel events, and economic loss for ASD surgery * Evaluate the prevalence and incidence of sacroiliac pain before/after complex adult spinal deformity surgery.

Interventions

PROCEDUREIndex or revision spine surgery for complex adult spinal deformity

Adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System.

Sponsors

International Spine Study Group Foundation
Lead SponsorOTHER
NuVasive
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

1. \>18 years of age at the time of treatment 2. EOS full body or standing 36" AP \& Lateral images of entire spine 3. Posterior spine fusion with pedicle screw fixation construct of 5 or more levels 4. Pedicle screw fixation to be supplemented proximally with NuVasive VersaTie system 5. Upper instrumented vertebra (UIV) terminating at a newly instrumented level 6. Lowest instrumented vertebra (LIV) sacrum/pelvis 7. Surgery scheduled to take place in the next 6 months

Exclusion criteria

1. Active spine tumor or infection 2. Deformity due to acute trauma 3. Prisoners 4. Women who are pregnant 5. Patient is unwilling or unable to complete questionnaires

Design outcomes

Primary

MeasureTime frameDescription
Scoliosis Research Society (SRS) 22rChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upScoliosis specific patient reported outcome
OswestryChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upSpine specific patient reported outcome
Veterans RAND 12 Item Health Survey (VR-12)Change from Preop to 3 months and 1, 2, 5 & 10 year follow-upPatient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - AnxietyChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upPatient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - DepressionChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upPatient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Pain InterferenceChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upPatient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Physical FunctionChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upPatient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Social SatisfactionChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upPatient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Social RoleChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upPatient reported outcome
Visual Analog Scale - Back PainChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upSelf-reported back pain on scale of 0 (No pain) to 10 (severe pain)
Visual Analog Scale - Leg PainChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upSelf-reported leg pain on scale of 0 (No pain) to 10 (severe pain)

Secondary

MeasureTime frameDescription
Edmonton Frail ScaleChange from Preop to 3 months and 1, 2, 5 & 10 year follow-upEvaluate frailty on scale of 0 to 17 where higher scores mean more frail
Canadian Study of Health and Aging (CSHA)Change from Preop to 3 months and 1, 2, 5 & 10 year follow-upFrailty scale of 1 to 9; higher scores mean more frail
Adverse Events3 months and 1, 2, 5 & 10 year post treatmentOccurrence of Adverse events meeting reporting criteria and their relationship to intervention throughout the study \[Time Frame: 3 months and 1, 2, 5 \& 10 year post treatment\]

Countries

United States

Contacts

CONTACTChristine Baldus, MH
baldusc@wustl.edu6184444130
CONTACTRay Pinteric
ray.pinteric@outlook.com
PRINCIPAL_INVESTIGATORShay Bess, MD

Presbyterian/St Luke's Medical Center

PRINCIPAL_INVESTIGATORJeffrey Mullin, MD

University at Buffalo, Department of Neurosurgery

PRINCIPAL_INVESTIGATORChristopher Shaffrey, MD

Duke University Medical Center, Section of Spine Surgery

PRINCIPAL_INVESTIGATORJustin Smith, MD

University of Virginia Medical Center, Department of Neurosurgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026